APA (7th ed.) Citation

Sanno, N., Urayama, K. Y., Mori, J., Yoshizawa, K., & Hashimoto, C. (2026). Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan. Neurology & Therapy, 15(4), 1807. https://doi.org/10.1007/s40120-026-00966-4

Chicago Style (17th ed.) Citation

Sanno, Naoko, Kevin Y. Urayama, Joji Mori, Kenichi Yoshizawa, and Chie Hashimoto. "Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan." Neurology & Therapy 15, no. 4 (2026): 1807. https://doi.org/10.1007/s40120-026-00966-4.

MLA (9th ed.) Citation

Sanno, Naoko, et al. "Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan." Neurology & Therapy, vol. 15, no. 4, 2026, p. 1807, https://doi.org/10.1007/s40120-026-00966-4.